Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases
Conclusion:
Buspirone's generally benign adverse effect profile makes it well suited for treating anxiety in individuals with DS in light of their common medical comorbidities.
Source: Journal of Developmental and Behavioral Pediatrics - Category: Child Development Tags: Brief Report Source Type: research
More News: Anxiety | Buspirone | Child Development | Down's Syndrome | Generalized Anxiety Disorder (GAD) | Pediatrics